Prostaglandin Endoperoxide

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 174 Experts worldwide ranked by ideXlab platform

Ahlim Tsai - One of the best experts on this subject based on the ideXlab platform.

Mattias L Blomberg - One of the best experts on this subject based on the ideXlab platform.

Wilfred Adrianus Van Der Donk - One of the best experts on this subject based on the ideXlab platform.

William L. Smith - One of the best experts on this subject based on the ideXlab platform.

  • Peroxidase site of Prostaglandin Endoperoxide H synthase-1: Docking and molecular dynamics studies with a Prostaglandin Endoperoxide analog
    The Journal of Physical Chemistry B, 2004
    Co-Authors: Steve A. Seibold, William L. Smith, Robert I. Cukier
    Abstract:

    Prostaglandin Endoperoxide H synthases-1 and -2 (PGHS-1 and PGHS-2) catalyze the first step in the biosynthetic pathway that produces Prostaglandins and thromboxanes. The fatty acid Endoperoxide/hydroperoxide substrate, PGG2, binds on the distal side of the heme that forms the peroxidase (POX) site of PGHSs and generates the alcohol PGH2 by cleaving the oxygen−oxygen bond of the 15-hydroperoxide group. The structure of the POX site of PGHS, as with other peroxidases, includes the invariant distal histidine residue His207 and a glutamine, Gln203. We report the first molecular dynamics (MD) simulation of a PGG2 analogue (pseudo-PGG2) bound to the peroxidase site of PGHS-1; pseudo-PGG2 lacks the Endoperoxide group and double bonds of PGG2 but is otherwise identical to PGG2. In the MD of the substrate-free state of PGHS-1, a water migrated to the heme active site to become the sixth ligand of the iron, and in time, it hydrogen bonded to other waters, forming chains that extended into the bulk solvent. A locat...

  • the enzymology of Prostaglandin Endoperoxide h synthases 1 and 2
    Prostaglandins & Other Lipid Mediators, 2002
    Co-Authors: William L. Smith, Inseok Song
    Abstract:

    We summarize the enzymological properties of Prostaglandin Endoperoxide H synthases (PGHs)-1 and -2, the enzymes that catalyze the committed step in Prostaglandin biosynthesis. These isoenzymes are closely related structurally and mechanistically. Each catalyzes a peroxidase and a cyclooxygenase reaction at spatially separate but neighboring, electronically interrelated active sites. The peroxidase is necessary to activate the cyclooxygenase; oxidation of the heme group of the peroxidase by peroxide leads to oxidation of a cyclooxygenase active site tyrosine. The tyrosine radical abstracts hydrogen from arachidonic acid to form an arachidonate radical which reacts sequentially with two oxygen molecules forming the intermediate product PGG2. PGG2 is then reduced by the peroxidase activity to PGH2. Based on the crystal structure of PGHS-1 arachidonate complex, it is now possible to envision how arachidonate is bound and oxygenation occurs. Recently, it has become possible to distinguish kinetically between the cyclooxygenase and peroxidase suicide inactivation reactions.

  • A Novel Method for Prostaglandin Endoperoxide H Synthase Activity in Individual Intact Cells
    Advances in experimental medicine and biology, 1997
    Co-Authors: Ikuo Morita, Sei-itsu Murota, Melvin Schindler, David L. Dewitt, William L. Smith
    Abstract:

    Prostaglandins are key mediators of inflammation1. Prostaglandin Endoperoxide H is synthesized by two related Prostaglandin Endoperoxide H synthases (PGHS-1 and PGHS-2, COX-1 and COX-2). PGHS-1 is a constitutive enzyme present in many but not all mammalian cells2. PGHS-2 is undetectable in most mammalian tissues, but expression of this isozyme can be induced by cytokines, growth factors, and tumor promoters3. This means that PGHS-2 will be closely related with inflammation. Therefore, a development of nonsteroidal anti-inflammatory drugs (NSAIDs) which inhibit PGHS-2 specifically is undergoing in the world. In the present paper, we will show a novel and convenient method for PGHS activity in intact individual cells.

  • Prostaglandin Endoperoxide h synthases 1 and 2
    Advances in Immunology, 1996
    Co-Authors: William L. Smith, David L. Dewitt
    Abstract:

    Publisher Summary The chapter compares and contrasts the structural and kinetic properties of Prostaglandin Endoperoxide H synthase-1 (PGHS-1) and -2. It also discusses the description of the interactions of the two isozymes with nonsteroidal anti-inflammatory drugs (NSAIDs). There are three general areas of study important to understanding more about PGHS isozymes: mechanisms of catalysis, regulation of gene expression, and subcellular functional independence. The chapter also explain how is arachidonic acid specifically channeled to PGHS-2 following mobilization in cells in response to TPA and how is the localization of PGHS-2 in the nuclear envelope important for PGHS-2 functioning. The chapter also describes the structures and regulation of expression of the PGHS-1 and -2 genes. The concepts that PGHS-1 and PGHS-2 represent two separate Prostaglandin biosynthetic pathways and two separate Prostaglandin signaling pathways need to be tested. The chapter also discusses how the two isozymes may act independently in intact cells to mediate the formation of prostanoids destined to act on cell surface and/or nuclear targets to mediate different biological and pathobiological events.

  • selective inhibition of Prostaglandin Endoperoxide synthase 1 cyclooxygenase 1 by valerylsalicylic acid
    Archives of Biochemistry and Biophysics, 1995
    Co-Authors: D K Bhattacharyya, M Lecomte, J Dunn, D J Morgans, William L. Smith
    Abstract:

    Aspirin causes a time-dependent inhibition of Prostaglandin Endoperoxide H synthases (PGHS)-1 and -2 by acetylating active site serines present in both isozymes. In the case of PGHS-1, aspirin acetylation blocks cyclooxygenase activity, apparently by preventing arachidonate binding to the cyclooxygenase active site. With PGHS-2, acetylation does not block substrate binding but rather alters the enzyme in such a way that the acetylated form of PGHS-2 produces 15R-hydroxy-eicosatetraenoic acid (15R-HETE) instead of the usual Prostaglandin Endoperoxide product. Based on these differences between PGHS-1 and PGHS-2, we reasoned that a salicylate ester containing an acyl group somewhat larger than the acetyl group of aspirin might be a selective inhibitor of PGHS-2. Accordingly, we prepared and tested eight different acyl salicylates as inhibitors of human (h) PGHS-1 and -2 expressed transiently in cos-1 cells. Valeryl(pentanoyl)salicylate (VSA) was the only compound in this series which showed isozyme selectivity, and, surprisingly, VSA inhibited hPGHS-1 much more effectively than hPGHS-2. Inhibition of hPGHS-1 by VSA was time-dependent. VSA also inhibited ovine PGHS-1 but did not inhibit the S530A mutant of ovine PGHS-1. This latter mutant, which lacks the active site serine hydroxyl group, is also refractory to inhibition by acetylsalicylate. Thus, we conclude that VSA acylates the active site serine of PGHS-1, VSA inhibited prostanoid synthesis by serum-starved murine NIH 3T3 cells which express only PGHS-1; in contrast, VSA caused only partial inhibition of prostanoid synthesis by serum-stimulated 3T3 cells which express both PGHS isozymes. Our results establish that VSA can be used as a reasonably selective inhibitor of PGHS-1.

Tadashi Tanabe - One of the best experts on this subject based on the ideXlab platform.